Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Appointed director
|
ARVINAS, INC. (ARVN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 1,324 shares
@ $24.3871, valued at
$32.3k
Exercised 4,010 restricted stock units
@ $0 |
|
03/03/2023 |
4
| Taylor Ian (Chief Scientific Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 1,051 shares
@ $29.53, valued at
$31k
Exercised 2,685 restricted stock units
@ $0 |
|
03/03/2023 |
4
| Houston John G (President and CEO) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 5,878 shares
@ $29.53, valued at
$173.6k
Exercised 17,510 restricted stock units
@ $0 |
|
03/03/2023 |
4
| Cassidy Sean A (CFO) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 1,745 shares
@ $29.53, valued at
$51.5k
Exercised 4,791 restricted stock units
@ $0 |
|
02/24/2023 |
4
| Cassidy Sean A (CFO) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 19,125 shares
@ $0 Granted 57,450 options to buy
@ $34.37, valued at
$2M
|
|
02/24/2023 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 19,125 shares
@ $0 Granted 57,450 options to buy
@ $34.37, valued at
$2M
|
|
02/24/2023 |
4
| Houston John G (President and CEO) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 61,975 shares
@ $0 Granted 186,250 options to buy
@ $34.37, valued at
$6.4M
|
|
02/24/2023 |
4
| Taylor Ian (Chief Scientific Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 19,125 shares
@ $0 Granted 57,450 options to buy
@ $34.37, valued at
$2M
|
|
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/16/2022 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 1,258 shares
@ $68.994, valued at
$86.8k
Exercised 4,010 restricted stock units
@ $0 |
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Kennedy Edward Moore Jr. (Director) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 10,192 options to buy
@ $36.79, valued at
$375k
|
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Margus Bradley Albert (Director) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 10,192 options to buy
@ $36.79, valued at
$375k
|
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/18/2022 |
4
| Morrison Briggs (Director) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 3,102 shares
@ $65.2393, valued at
$202.4k
Sold 7,104 shares
@ $66.0692, valued at
$469.4k
Sold 10,754 shares
@ $67.0344, valued at
$720.9k
Exercised 16,188 options to buy
@ $16, valued at
$259k
|
|
04/01/2022 |
4
| Taylor Ian (Chief Scientific Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Gifted 3,000 shares
@ $0 |
|
03/15/2022 |
4
| Cassidy Sean A (CFO) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 15,000 shares
@ $70, valued at
$1.1M
Exercised 15,000 options to buy
@ $16, valued at
$240k
|
|
03/04/2022 |
4
| Taylor Ian (Chief Scientific Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 869 shares
@ $63.94, valued at
$55.6k
Granted 67,000 options to buy
@ $64.19, valued at
$4.3M
Exercised 2,686 restricted stock units
@ $0 |
|
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Granted 67,000 options to buy
@ $64.19, valued at
$4.3M
|
|
03/04/2022 |
4
| Houston John G (President and CEO) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 6,024 shares
@ $63.94, valued at
$385.2k
Granted 200,500 options to buy
@ $64.19, valued at
$12.9M
Exercised 17,511 restricted stock units
@ $0 |
|
03/03/2022 |
4
| Taylor Ian (Chief Scientific Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Exercised 596 options to buy
@ $16, valued at
$9.5k
Exercised 925 options to buy
@ $16, valued at
$14.8k
Exercised 1,979 options to buy
@ $16, valued at
$31.7k
|
|
02/17/2022 |
4
| Taylor Ian (Chief Scientific Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 5,867 shares
@ $71.74, valued at
$420.9k
Sold 5,766 shares
@ $72.55, valued at
$418.3k
Sold 4,126 shares
@ $73.68, valued at
$304k
Sold 3,841 shares
@ $74.64, valued at
$286.7k
Sold 300 shares
@ $75.8, valued at
$22.7k
Sold 100 shares
@ $76.58, valued at
$7.7k
Exercised 20,000 options to buy
@ $19.36, valued at
$387.2k
|
|
01/19/2022 |
4
| Morrison Briggs (Director) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 9,919 shares
@ $64.332, valued at
$638.1k
Sold 3,833 shares
@ $65.2417, valued at
$250.1k
Sold 5,100 shares
@ $67.2831, valued at
$343.1k
Sold 2,108 shares
@ $67.6927, valued at
$142.7k
Exercised 16,188 options to buy
@ $16, valued at
$259k
|
|
01/04/2022 |
4
| Peck Ronald (Chief Medical Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 11,371 shares
@ $80.35, valued at
$913.7k
Sold 8,629 shares
@ $80.96, valued at
$698.6k
Exercised 14,375 options to buy
@ $47.38, valued at
$681.1k
Exercised 5,625 options to buy
@ $26.58, valued at
$149.5k
|
|
12/21/2021 |
4
| Cassidy Sean A (CFO) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 15,000 shares
@ $70, valued at
$1.1M
Exercised 15,000 options to buy
@ $16, valued at
$240k
|
|
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2021 |
4
| Taylor Ian (Chief Scientific Officer) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 6,856 shares
@ $83.0673, valued at
$569.5k
Sold 6,660 shares
@ $84.1429, valued at
$560.4k
Sold 6,484 shares
@ $84.9545, valued at
$550.8k
Exercised 12,206 options to buy
@ $16, valued at
$195.3k
Exercised 7,794 options to buy
@ $19.36, valued at
$150.9k
|
|
|
|
|